Mapi Pharma

Mapi Pharma

Clinical-stage pharmaceutical company engaged in the development of improved extended-release versions of existing, commercially successful products.
  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

N/A

IPO

$10.0m

Post IPO Equity
*

$10.0m

Post IPO Equity
*

$10.0m

Post IPO Equity
*

$2.5m

Grant
Total Funding€2.3m

Recent News about Mapi Pharma

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.